null

SMILES: COc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)(F)F)sc4CC3)OC2)on1

InChI Key: InChIKey=RVWPDWZOIDVHIU-LSDHHAIUSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 476787   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
D(3) dopamine receptor (Homo sapiens (Human))	BDBM476787 (US10870660, Compound III-199 | US11345716, Compoun...) Show SMILES COc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)(F)F)sc4CC3)OC2)on1 |r| Show InChI InChI=1S/C22H29F3N4O5S/c1-31-20-11-16(34-28-20)10-19(30)26-14-2-3-15(32-12-14)4-7-29-8-5-17-18(6-9-29)35-21(27-17)33-13-22(23,24)25/h11,14-15H,2-10,12-13H2,1H3,(H,26,30)/t14-,15+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	0.200	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SHIONOGI & CO., LTD. US Patent					Assay Description 225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...				US Patent US10870660 (2020)
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM476787 (US10870660, Compound III-199 | US11345716, Compoun...) Show SMILES COc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)(F)F)sc4CC3)OC2)on1 |r| Show InChI InChI=1S/C22H29F3N4O5S/c1-31-20-11-16(34-28-20)10-19(30)26-14-2-3-15(32-12-14)4-7-29-8-5-17-18(6-9-29)35-21(27-17)33-13-22(23,24)25/h11,14-15H,2-10,12-13H2,1H3,(H,26,30)/t14-,15+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		0.200	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
D(2) dopamine receptor (Homo sapiens (Human))	BDBM476787 (US10870660, Compound III-199 | US11345716, Compoun...) Show SMILES COc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)(F)F)sc4CC3)OC2)on1 |r| Show InChI InChI=1S/C22H29F3N4O5S/c1-31-20-11-16(34-28-20)10-19(30)26-14-2-3-15(32-12-14)4-7-29-8-5-17-18(6-9-29)35-21(27-17)33-13-22(23,24)25/h11,14-15H,2-10,12-13H2,1H3,(H,26,30)/t14-,15+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		520	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
D(2) dopamine receptor (Homo sapiens (Human))	BDBM476787 (US10870660, Compound III-199 | US11345716, Compoun...) Show SMILES COc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCc4nc(OCC(F)(F)F)sc4CC3)OC2)on1 |r| Show InChI InChI=1S/C22H29F3N4O5S/c1-31-20-11-16(34-28-20)10-19(30)26-14-2-3-15(32-12-14)4-7-29-8-5-17-18(6-9-29)35-21(27-17)33-13-22(23,24)25/h11,14-15H,2-10,12-13H2,1H3,(H,26,30)/t14-,15+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	520	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
SHIONOGI & CO., LTD. US Patent					Assay Description 225 nL of the solutions of the non-specific ligand or the compounds of the present invention at each concentration (in case of vehicle, final concent...				US Patent US10870660 (2020)
					More data for this Ligand-Target Pair